CWEB

FDA Declines To Approve Pfizer Biosimilar Of Roche’s Cancer Drug – CWEB.com U.S. regulators declined to approve the company’s biosimilar of Roche’s blockbuster treatment for breast cancer, Herceptin. Biologics are produced from living cells. They are very difficult to copy with exact precision. Generic type versions of these drugs are called biosimilars. The fate of Pfizer ( PFE ) is in the spotlight. Challenging times ahead for the company as “Merck Sells Consumer Business”. Pfizer stated last October it was reviewing strategic alternatives for its consumer healthcare unit and is expected to make a decision in 2018. Pfizer ( PFE ) chairman and CEO Ian Read talked with Citi Group analyst Andrew Baum and stated that an acquisition of Bristol-Myers Squibb (NYSE: BMS ) is off the table for now. Other contenders for Pfizer to acquire could be I think Sangamo Therapeutics (NASDAQ: SGMO ), Celgene (NASDAQ: CELG ), and Madrigal Pharmaceuticals (NASDAQ: MDGL ). Celgene dominates...

Eli Lilly And Company Is Scheduled To Present First-Quarter Results - CWEB.com Eli Lilly and Company ( LLY ) this week, management is scheduled to present first-quarter results. Eli Lilly and, Incyte Corporation, meet with the FDA on April 23. The two partners' new rheumatoid arthritis tablet Olumiant sells to consumers in Europe. Her in the U.S. the FDA rejected an application last year citing evidence suggesting the drug could be linked to dangerous blood clots. Incyte’s and Elu Lily’s application seven clinical trials that enrolled about 3,100 patients. It was found that Olumiant suppresses the immune system. Five patients in the trial received blood clots. Lilly looks to introduce the drug with a recommended 4 mg dose that tapers down to 2 mg, except for treatment-resistant patients. That would include running a new trial that could take years moving forward. The FDA is looking for more evidence that the drug is safe. The drug Kevzara introduced by Novartis and Rege...

Can Pfizer, Eli Lilly, Bayer AG Or Glaxo Smith And Kline Buy AYTU - CWEB.com The statistic shows the revenue of  Pfizer's  ( PFE ) top product  Viagra  from 2003 to 2017. Pfizer Inc. is a multinational pharmaceutical corporation. The company is headquartered in Midtown Manhattan, New York City. In 2008, Pfizer's  Viagra  generated some 1.93 billion U.S. dollars of revenue. Viagra is used primarily to treat erectile dysfunction and pulmonary arterial hypertension. Viagra's patent protection in the U.S. was prolonged until April 2020. Last year,  Pfizer's  ( PFE )  Viagra  had worldwide sales of $1.7 billion. Eli Lilly & Co  ( LLY )  Cialis  is also a product for Erectile Dysfunction and has sold Estimated  2016 U.S.  sales : $1.469 billion U.S  Bayer AG  ( OTCPK:BAYRY ) and  Glaxo Smith Kline  ( GSK ) both have marketed  Levitra  which also has estimated revenu...

Sears Is Making A Comeback - CWEB.com Sears ( SHLD ) is making a comeback right now and will sustain the momentum going forward. There will be a conference center that will reside where the old Sears automotive building was and Sears will host an 18,000-square-foot facility selling home goods such as mattresses and appliances. Anything ordered online at  Sears.com  can also be picked up in these store locations. Three new tenants will be leasing a small portion of the Sears building. For Sears, closing stores can be a path to profitability and beefing up their online presence. Sears has made a deal with Amazon to start selling its Kenmore-branded appliances online that are compatible with Amazon’s Alexa. Comparing to all other retailers in the industry including Kohls, Costco, Nordstrom, Macys, Walmart, Amazon, Sears holding has a potential turnaround of going over $20-$30 within a year by focusing on shop your way and other new ventures. Sears Holdings Corpor...

CWEB.com  - Johnson & Johnson Beats Earnings Estimates By Leslie Cohen Managing Editor Johnson & Johnson ( JNJ ) Johnson & Johnson’s first-quarter earnings beat and exceeded expectations on 4-17-2018. With a lot of momentum carrying from 2017 to 2018, the results were positive. Earnings came out at: $2.06 per share vs. $2.02 per share expected. Respectively, revenue topped to $20 billion vs. $19.46 billion that was expected. The new US tax legislation law gives J&J more flexibility to invest on a global basis and within the US. Strong investments of 30 billion dollars over a four year period will occur in new technologies that will be manufactured in the US. Johnson & Johnson’s role as a biotech buyer gives them a fifty percent growth rate for the company. J&J’s consumer business has lagged with the other occupants in this sector. Baby care product sales fell down to $457 million from $455 million, a 3% percent decrease year-over-year when exclu...

CWEB - Barbara Bush, In Failing Health, Says She Won’t Seek Further Treatment By Leslie Cohen Managing Editor Former first lady of former President George H. W. Barbara Bush is in failing health. She has been suffering from Chronic Obstructive Pulmonary Disease, (COPD), and congestive heart failure. Her diseases have progressed in the past couple of days. She has opted for care at home and has decided not to return to the hospital. This is a very difficult time for the family. Former President George H. W. Bush and their daughter Doro, along with her sons Marvin and Neil are at her bedside. Barbara Bush wife of George H. W. Bush, served as the 37th First Lady of the United States from 1989 to 1993. Since the Former President George W. Bush left the White House, they have raises more than a billion dollars for charity, specifically for the of cause of literacy. Former President George H.W Bush quotes in his book, “All the Best” "We are two people, but we are one...

CWEB - Uber Wins Landmark Victory in Federal Court By Leslie Cohen Managing Editor Uber Technologies Inc. the peer-to-peer ridesharing just has just had a landmark victory when a federal judge U.S. District Judge Michael Baylson ruled Thursday, April 12th, 2018, that UberBlack drivers will not be classified as employees. Razak v. Uber Technologies was filed in February 2016. The ruling states that under the Fair Labor Standards Act, Uber does not maintain enough control over the drivers, and they will be classified as independent contractors. This is the first case in the ridesharing segment of the new economy. Judge Baylosn stated that since the drivers make their own hours, they are not employees under the Fair Labor Standards Act guidelines. Uber drivers do not get the benefits of workers who are full-time employees that can receive health insurance, 401K plans, vacation time, and other benefits that come with full-time employment. Jeremy Abay, one of the lawyers for th...

Sprint And T- Mobile Merger Talks Begin - CWEB.com Sprint and T- Mobile Merger Talks Begin By: Leslie Cohen Managing Editor Sprint Corp. ( S ) and T-Mobile US Inc. ( TMUS ) have rekindled merger talks. After four years, the two companies that have been fierce rivals are exploring a combination for the third time in four years. Shares of Sprint Corp. ( S ) , +18.00% spiked higher in midday trade, Tuesday 4/10/2018. Last time, merger talks were left in disarray after the companies could not agree on who would take control over the combined entity. Japan’s Softbank Corp. owns about 85 percent of Sprint and T-Mobile ( TMUS ) is controlled by Germany’s Deutsche Telekom AG. Looking to expand into the 5G wireless technology, a merger between Sprint  ( S ) at T- Mobile ( TMUS ) can give it an edge to compete and serve 127 million customers if combined. Sprint stated back in March that $6 billion annually, over the next several fiscal year...

Boeing Delivers - CWEB.com By Leslie Cohen Managing Editor Boeing Co. U.S.: ( BA ) was able to deliver record setting results for commercial aircraft deliveries in 2017. The tax law changes implemented by President Trump have given Boeing the ability to invest billions of dollars into its business. Lion Air Group, the budget airline based in Indonesia announced Tuesday the order for 50 Boeing Co. 737 Max 10 jets, adding more seats to its planes with the growth of travel in the country. The contract is worth $6.24 billion. Boeing increases first-quarter deliveries by nearly 9 percent. It has acquired $11.5 billion in free cash flow. We could see an upside of 20%-25% annual growth over the next five years. As of April 10 th many top analysts rate it a buy including Cowen % Company, Edward Jones, Jeffries and Co., JP. Morgan Securities and Morgan Stanley. CWEB Analyst's have initiated a Buy Rating for Boeing Co. U.S.: ( BA ), and a Price Target of $400 within 12 mont...

Reasons To Consider General Motors A Buy - CWEB.com General Motors ( GM ) has  an impressive dividend yield that has free cash flow support.   GM outperformed the domestic automakers in January. GM outsold more light trucks than Ford. With a robust portfolio of electric vehicles projected over the next half decade, GM is positioned at the front of the pack in this rapidly growing space. General Motors ( GM ) shares enjoy enormous upside potential due to record-setting profitability, robust free cash flow generation, reduced correlation to the overall North American automotive market, a strong position in electric cars and huge business in China. GM China (NYSE: GM ) reports sales increased 2.0% in March to 352,346 units. Cadillac sales rose 46% to 18K units (monthly record) to help offset drops for the Wuling and Baojun brands. GM China YTD sales +7.9% to 986,052 units. General Motors reported superb March results for the U.S. marke...

What Will Take For AYTU To Reach $20 A Share - CWEB.com For men suffering with low testosterone Aytu Bioscience's  ( OTCQX:AYTU )FDA-approved, Natesto, a nasally administered TRT is a more effective and safer treatment than TLANDO. Natesto has the added advantage of not affecting LH and FSH hormone levels. Aytu Bioscience ( OTCQX:AYTU ) competitors  Lipocine's ( LPCN ) TLANDO medication for men with low testosterone was turned down on 1/10/2018, by the FDA's Bone, Reproductive and Urologic Drugs Advisory Committee.  The FDA voted 13-6 against Lipocine's ( LPCN ) TLANDO with concerns raised about risks to patients. Currently  Lipocine's ( LPCN ) is trading around  $1.63 So  Aytu Bioscience ( OTCQX:AYTU ) is a lot cheaper with a higher potential and trading around  0.63  cents. On January 10, 2018, both Clarus ( OTC:CLAR ) Therapeutics which trades around  $6.70 ...

Viacom Reject Takeover Offer From CBS Below Its $12.5 Billion Valuation - CWEB.com By: Leslie Cohen Managing Editor CBS Corp. ( CBS ) makes an offer for Viacom with an all stock purchase offer with the contingency it keeps it the same management team leading the organization- at least for now. Viacom’s ( VIA)  current valuation is $12.5 billion. Viacom rejected this offer of 0.55 shares of CBS in an all-stock deal for each share of Viacom. CBS proposes that eventually current CEO Bob Bakish would no longer run the company, and that Chief Executive Leslie Moonves and President Joe Ianniello would run the combined company for the foreseeable future. Sumner Redstone’s holding company National Amusements Inc., holds an 80% voting stake in CBS and Viacom Redstone’s daughter, Shari Redstone has wanted the two companies to be combined for quite some time. CBS ( CBS ) shares have not been rising. Viacom  ( VIA)  is still valued at a bargain with 8x fo...

Is Kraft Heinz A Buy At This Levels - CWEB.com Shares of The Kraft Heinz Company ( KHC ) have had a rough year. With high $90s almost a year ago, shares are at 52-week lows trading around $63. The brand portfolio is robust, and the dividend is yielding much higher than historical norms. Organic growth is weak, likely due to the company’s lack of expansion efforts outside of North America. The yield is highly competitive, but is likely not enough of a buffer in the short term. Kraft Heinz ( KHC ) ended 2017 on a softer note after the third-quarter results provided reasons to become more upbeat. The only bright news is the fact that the valuation has continuously come down, reducing expectations along the way. Company has started to aggressively pay down debt. Interest rate on the debt is 3.8%, which is an expense that will not impede future dividend increases. The dividend has increased an average 12% per year since 2013. Even if we reduce fut...

A Budget Product From Walmart That Will Change The Acne Pharmaceutical Industry Forever – CWEB.com An article published by the Daily mail 20 year old who has suffered from horrible acne for years managed to wipe her face clean of any blemishes using only products from  Walmart . Rekik Neway from Los Angeles cured her pimples by using simple natural products of witch hazel, tea tree oil, bentonite clay and rose water. Read more:  http://www.dailymail.co.uk/femail/article-5555061/Girl-completely-clears-acne-12-products-Walmart.html#ixzz5BoUI0PqQ

Apple Touchless Control – CWEB.com Apple (NASDAQ: AAPL ) the technology giant is also developing curved screens for its phones, according to a story Wednesday. A new report out of Bloomberg this morning suggests that Apple is developing two new pieces of technology for future iPhone models: one is touch less gesture control and the other is a curved display. Both projects are said to be at the early stages of research and development, at least two years away from potentially making it into consumer devices. The control feature would let iPhone users perform some tasks by moving their finger close to the screen without actually tapping it. The technology likely won’t be ready for consumers for at least two years, if Apple chooses to go forward with it, a person familiar with the work said. Apple (NASDAQ: AAPL ) is also on the path to $1 Trillion Market Cap. CWEB Analyst's Reiterates a Buy Rating for Apple (NASDAQ: AAPL ) and a price target of $350 within 12 months. ...